CompletedNot Applicable

Assessing the Benefits of Robotic and Laparoscopic Surgery for Mid and Low Rectal Cancer in Patients: The Charlson Comorbidity Index (CCI)

China505 participantsStarted 2019-01-01

Plain-language summary

This retrospective study collected participants who underwent robotic or laparoscopic anterior resection for rectal cancer at the North People's Hospital in Jiangsu from January 2019 to January 2023.

Who can participate

Age range55 Years – 85 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: The criteria include: (1) pathology of low rectal cancer (within 10 cm from the anal margin); (2) access to comprehensive pathological and computed tomography (CT) data; (3) completeness of clinical data. Exclusion Criteria: patients with other malignant tumors besides rectal cancer, benign disease surgery, and emergency surgery.

What they're measuring

postoperative recurrence rate

Timeframe: 2018-2024

Trial details

NCT IDNCT06396845

SponsorDaorong Wang

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2022-01-01

View on ClinicalTrials.gov More Robotic trials